SCHEMBL6020548

SCHEMBL6020548

N#CCCNC(=O)C(Cc1ccccc1)NC(=O)Nc1ccc2c(c1)OCO2

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.56
NPC1 O15118 7/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
GSK3B P49841 1/20 0.55
MAPT P10636 5/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
ATM Q13315 1/20 0.47
POLB P06746 1/20 0.46
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
CTSS P25774 1/20 0.46
TACR2 P21452 4/20 0.46
PKM P14618 1/20 0.45
FPR2 P25090 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6021354 0.92 CHRM2 (0.47) RAB9ANPC1SMN1; SMN2GSK3BMAPT
SCHEMBL6021238 0.91 GSK3B (0.58) RAB9ANPC1SMN1; SMN2GSK3BMAPT
SCHEMBL6019285 0.91 KDM4E (0.55) RAB9ANPC1SMN1; SMN2GSK3BMAPT
SCHEMBL6020696 0.85 RAB9A (0.49) RAB9ANPC1SMN1; SMN2GSK3BMAPT
SCHEMBL6020985 0.84 CTSL (0.48) RAB9ANPC1SMN1; SMN2GSK3BMAPT
SCHEMBL6019399 0.84 MAPK1 (0.66) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL6020827 0.84 CTSL (0.53) RAB9ANPC1SMN1; SMN2GSK3BMEN1
SCHEMBL6021750 0.83 CTSS (0.58) RAB9ANPC1SMN1; SMN2GSK3BMAPT
SCHEMBL6020314 0.83 HTT (0.51) RAB9ANPC1SMN1; SMN2GSK3BMAPT
SCHEMBL6020189 0.83 CTSS (0.57) CTSLCTSBCTSSTACR2FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US claimed
WO-2004056755-A2 COMPOUNDS FOR THE INHIBITION OF NON-PROTEOLYTIC ENZYMES JERENI AG (DE) 2004-07-08 WO claimed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP claimed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP claimed
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US disclosed
EP-1575903-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES Jerini AG (DE) 2005-09-21 EP disclosed
WO-2004065353-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES JERINI AG (DE) 2004-08-05 WO disclosed
WO-2004056755-A2 COMPOUNDS FOR THE INHIBITION OF NON-PROTEOLYTIC ENZYMES JERENI AG (DE) 2004-07-08 WO disclosed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP disclosed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252813-A1 Apparatus for curing a composite laminate DHX29, HDHD5, DHRS9 RAB9A 841/4885NPC1 3877/4885SMN1; SMN2 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.